CI Private Wealth »

Context Therapeutics shares owned by CI Private Wealth

Quarter-by-quarter ownership of Context Therapeutics (CNTX) shares owned by CI Private Wealth from 13F filings

Historical chart of CI Private Wealth investment in Context Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Context Therapeutics held by CI Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Context Therapeutics by CI Private Wealth

Quarter filed Position value Share count Share price at filing
2025-12-31 $22k 15k 1.47

More positions owned by CI Private Wealth

Blackrock (BLK)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Monolithic Power Systems (MPWR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Kla Corp Com New (KLAC)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Ge Vernova (GEV)

View all positions for CI Private Wealth

Top funds holding Context Therapeutics

MPM Oncology Impact Management
Blue Owl Capital Holdings
Deep Track Capital
Nextech Invest
Avidity Partners Management
Dr. Jeffrey R. Jay, M.D.
Franklin Resources
Vanguard Group
Marshall Wace
Blackstone Group
Alyeska Investment Group
Sio Capital Management
BlackRock
Geode Capital Management
Renaissance Technologies

View all funds holding Context Therapeutics